Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (APAP)

B. Trapnell (Cincinnati, United States of America), Y. Inoue (Osaka, Japan), F. Bonella (Essen, Germany), C. Morgan (London, United Kingdom), S. Jouneau (Rennes, France), E. Bendstrup (Aarhus, Denmark), I. Campo (Pavia, Italy), S. Papiris (Athens, Greece), E. Yamaguchi (Aichi, Japan), E. Cetinkaya (Istanbul, Turkey), M. Ilkovich (St. Petersburg, Russian Federation), M. Kramer (Petah Tikva, Israel), M. Veltkamp (Nieuwegein, Netherlands), M. Kreuter (Heidelberg, Germany), T. Baba (Yokohama, Japan), C. Ganslandt (Austin, United States of America), I. Tarnow (Austin, United States of America), G. Waterer (Perth, Australia), T. Jouhikainen (Austin, United States of America)

Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Session: ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Session type: Clinical trials session
Number: 3803

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Trapnell (Cincinnati, United States of America), Y. Inoue (Osaka, Japan), F. Bonella (Essen, Germany), C. Morgan (London, United Kingdom), S. Jouneau (Rennes, France), E. Bendstrup (Aarhus, Denmark), I. Campo (Pavia, Italy), S. Papiris (Athens, Greece), E. Yamaguchi (Aichi, Japan), E. Cetinkaya (Istanbul, Turkey), M. Ilkovich (St. Petersburg, Russian Federation), M. Kramer (Petah Tikva, Israel), M. Veltkamp (Nieuwegein, Netherlands), M. Kreuter (Heidelberg, Germany), T. Baba (Yokohama, Japan), C. Ganslandt (Austin, United States of America), I. Tarnow (Austin, United States of America), G. Waterer (Perth, Australia), T. Jouhikainen (Austin, United States of America). Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (APAP). 3803

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: